Client Companies

If you are about to recruit a new NED or Chair, why not consider a fresh perspective?

Bioscience NEDs offers:

  • a gateway to a talent pool who really understand the sector, its challenges and issues
  • access to seasoned individuals who come with new ideas, contacts and the appetite to genuinely make a difference
  • a fairly priced fee model which reflects the remuneration, effort and outcome and encourages Boards to think beyond their own network

Our approach
Experience shows that a focused briefing, and thorough consultation with all key stakeholders in the selection process, ensures clarity and results in a well-matched short list.

By applying our simple, but effective, diagnostic process, we build an accurate candidate profile that considers your requirements from every aspect - from Board structure and cultural fit, through to the skills and experience required for the role. We then consult our network of senior- and Board-level contacts to find those candidates who possess the relevant experience and flair.

The importance of candidate due diligence
As you would expect, we thoroughly assess the capabilities and expertise of any candidate that we represent. As a result of our reach within the life science sector, and the tight network of senior contacts, we find informal discussions an invaluable means of really understanding a candidate's contribution. It can also provide valuable insights into cultural dynamics - essential to ensure a successful working relationship.

Why not get in touch for a preliminary discussion?

Quite apart from the governance and stewardship required of NED's to satisfy shareholders' interests, I have found the more valuable NED's have provided balance to the Boards on which they serve. They achieve this by complementing the skill set of the executive Directors, challenging the execs' proposals and judgment, often providing an additional channel of communication with third parties to help cement a transaction, and generally serving as confidante and supporter of the CEO in his/her decision making.

Raymond Spencer, Interim CFO Summit plc, Partner at Bio-CFO